Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: OSTEOPOROSIS - DRUG THERAPY , . Treffer: 33

2021

Obermayer-Pietsch, B; Fössl, I; Dimai, HP [Long-term treatment concepts for osteoporosis].
INTERNIST. 2021; 62(5): 474-485. Doi: 10.1007/s00108-021-00993-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Pepe, J; Body, JJ; Hadji, P; McCloskey, E; Meier, C; Obermayer-Pietsch, B; Palermo, A; Tsourdi, E; Zillikens, MC; Langdahl, B; Ferrari, S Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
J Clin Endocrinol Metab. 2020; 105(8): Doi: 10.1210/clinem/dgaa306 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Fahrleitner-Pammer, A; Wagner, D; Krisper, P; Amrein, K; Dimai, H Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
Osteoporos Int. 2017; 28(3):1149-1152 Doi: 10.1007/s00198-016-3858-2 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Harvey, NC; Biver, E; Kaufman, JM; Bauer, J; Branco, J; Brandi, ML; Bruyère, O; Coxam, V; Cruz-Jentoft, A; Czerwinski, E; Dimai, H; Fardellone, P; Landi, F; Reginster, JY; Dawson-Hughes, B; Kanis, JA; Rizzoli, R; Cooper, C The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
Osteoporos Int. 2017; 28(2):447-462 Doi: 10.1007/s00198-016-3773-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kanis, JA; Cooper, C; Rizzoli, R; Abrahamsen, B; Al-Daghri, NM; Brandi, ML; Cannata-Andia, J; Cortet, B; Dimai, HP; Ferrari, S; Hadji, P; Harvey, NC; Kraenzlin, M; Kurth, A; McCloskey, E; Minisola, S; Thomas, T; Reginster, JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
Osteoporos Int. 2017; 28(7):2023-2034 Doi: 10.1007/s00198-017-4009-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tsourdi, E; Langdahl, B; Cohen-Solal, M; Aubry-Rozier, B; Eriksen, EF; Guañabens, N; Obermayer-Pietsch, B; Ralston, SH; Eastell, R; Zillikens, MC Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
Bone. 2017; 105(21-22):11-17 Doi: 10.1016/j.bone.2017.08.003
Web of Science PubMed FullText FullText_MUG

 

2016

Brozek, W; Reichardt, B; Zwerina, J; Dimai, HP; Klaushofer, K; Zwettler, E Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
Osteoporos Int. 2016; 27(1):387-396 Doi: 10.1007/s00198-015-3415-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Khan, AA; Morrison, A; Kendler, DL; Rizzoli, R; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Dabagh, RA; Davison, KS; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
J Clin Densitom. 2016; 20(1):8-24 Doi: 10.1016/j.jocd.2016.09.005
Web of Science PubMed FullText FullText_MUG

 

Obermayer-Pietsch, B; Schwetz, V [Biochemical markers of bone metabolism and their importance].
Z Rheumatol. 2016; 75(5):451-458 Doi: 10.1007/s00393-016-0083-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37 Doi: 10.1007/s10006-012-0376-z
PubMed FullText FullText_MUG

 

2013

Jacobsen, C; Metzler, P; Rössle, M; Obwegeser, J; Zemann, W; Grätz, KW Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Clin Oral Investig. 2013; 17(1):167-175 Doi: 10.1007/s00784-012-0708-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Bieglmayer, C; Dimai, HP; Gasser, RW; Kudlacek, S; Obermayer-Pietsch, B; Woloszczuk, W; Zwettler, E; Griesmacher, A Biomarkers of bone turnover in diagnosis and therapy of osteoporosis : A consensus advice from an Austrian working group.
Wien Med Wochenschr. 2012; 162(21-22):464-477 Doi: 10.1007/s10354-012-0133-9
PubMed FullText FullText_MUG

 

Boonen, S; Reginster, JY; Kaufman, JM; Lippuner, K; Zanchetta, J; Langdahl, B; Rizzoli, R; Lipschitz, S; Dimai, HP; Witvrouw, R; Eriksen, E; Brixen, K; Russo, L; Claessens, F; Papanastasiou, P; Antunez, O; Su, GQ; Bucci-Rechtweg, C; Hruska, J; Incera, E; Vanderschueren, D; Orwoll, E; Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis.
N ENGL J MED. 2012; 367(18): 1714-1723. Doi: 10.1056/NEJMoa1204061 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, C; Metzler, P; Obwegeser, JA; Zemann, W; Graetz, KW Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years?
Swiss Med Wkly. 2012; 142(5):w13605-w13605 Doi: 10.4414/smw.2012.13605 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lekamwasam, S; Adachi, JD; Agnusdei, D; Bilezikian, J; Boonen, S; Borgstrom, F; Cooper, C; Perez, AD; Eastell, R; Hofbauer, LC; Kanis, JA; Langdahl, BL; Lesnyak, O; Lorenc, R; McCloskey, E; Messina, OD; Napoli, N; Obermayer-Pietsch, B; Ralston, SH; Sambrook, PN; Silverman, S; Sosa, M; Stepan, J; Suppan, G; Wahl, DA; Compston, JE; A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
Osteoporos Int. 2012; 23(9):2257-2276 Doi: 10.1007/s00198-012-1958-1
Web of Science PubMed FullText FullText_MUG

 

Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336 Doi: 10.1097/TP.0b013e31823f7f68 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Dobnig, H A review of the health consequences of the vitamin D deficiency pandemic.
J NEUROL SCI. 2011; 311(1-2): 15-18. Doi: 10.1016/j.jns.2011.08.046
Web of Science PubMed FullText FullText_MUG

 

Rintelen, B; Bobacz, K; Höfle, G; Peichl, P; Rainer, F; Weber, K; Gaugg, M; (Arbeitsgruppe Osteologie der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation – ÖGR) [Prophylaxis and therapy of the glucocorticoid-induced osteoporosis - a review of recent guidelines].
Wien Klin Wochenschr. 2011; 123(21-22):633-644 Doi: 10.1007/s00508-011-0042-8
Web of Science PubMed FullText FullText_MUG

 

2010

Pietschmann, P; Azizi-Semrad, U; Pils, K; Fahrleitner-Pammer, A; Resch, H; Dobnig, H Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences.
Wien Klin Wochenschr. 2010; 122(17-18): 532-537. Doi: 10.1007/s00508-010-1428-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Dobnig, H; Stepan, JJ; Burr, DB; Li, J; Michalská, D; Sipos, A; Petto, H; Fahrleitner-Pammer, A; Pavo, I Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate *
J Bone Miner Res. 2009; 24(12): 1998-2006. Doi: 10.1359/jbmr.090527 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Obermayer-Pietsch, BM; Marin, F; McCloskey, EV; Hadji, P; Farrerons, J; Boonen, S; Audran, M; Barker, C; Anastasilakis, AD; Fraser, WD; Nickelsen, T Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment.
J BONE MINER RES. 2008; 23(10): 1591-1600. Doi: 10.1359/jbmr.080506 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rajzbaum, G; Jakob, F; Karras, D; Ljunggren, O; Lems, WF; Langdahl, BL; Fahrleitner-Pammer, A; Walsh, JB; Gibson, A; Tynan, AJ; Marin, F Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting.
Curr Med Res Opin. 2008; 24(2): 377-384. Doi: 10.1185/030079908X261087
Web of Science PubMed FullText FullText_MUG

 

Wutzl, A; Biedermann, E; Wanschitz, F; Seemann, R; Klug, C; Baumann, A; Watzinger, F; Schicho, K; Ewers, R; Millesi, G Treatment results of bisphosphonate-related osteonecrosis of the jaws.
Head Neck. 2008; 30(9): 1224-1230. Doi: 10.1002/hed.20864
Web of Science PubMed FullText FullText_MUG

 

2006

Dobnig, H; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Osteoporos Int. 2006; 17(5):693-703 Doi: 10.1007/s00198-005-0035-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ralston, SH; Uitterlinden, AG; Brandi, ML; Balcells, S; Langdahl, BL; Lips, P; Lorenc, R; Obermayer-Pietsch, B; Scollen, S; Bustamante, M; Husted, LB; Carey, AH; Diez-Perez, A; Dunning, AM; Falchetti, A; Karczmarewicz, E; Kruk, M; van Leeuwen, JPTM; van Meurs, JBJ; Mangion, J; McGuigan, FEA; Mellibovsky, L; del Monte, F; Pols, HAP; Reeve, J; Reid, DM; Renner, W; Rivadeneira, F; van Schoor, NM; Sherlock, RE; Ioannidis, JPA Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: The GENOMOS study
PLOS MED. 2006; 3: 515-523. Doi: 10.1371/journal.pmed.0030090 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Dobnig, H A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.
EXPERT OPIN PHARMACOTHER. 2004; 5(5): 1153-1162. Doi: 10.1517/14656566.5.5.1153
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Aringer, M; Vierhapper, H; Graninger, MT; Bernecker, P; Smolen, JS; Pietschmann, P Successful treatment of high turnover osteoporosis in a patient with adrenocortical insufficiency.
Wien Klin Wochenschr. 2000; 112(7):334-337 (- Case Report)
Web of Science PubMed

 

Orwoll, E; Ettinger, M; Weiss, S; Miller, P; Kendler, D; Graham, J; Adami, S; Weber, K; Lorenc, R; Pietschmann, P; Vandormael, K; Lombardi, A Alendronate for the treatment of osteoporosis in men.
N Engl J Med. 2000; 343(9):604-610 Doi: 10.1056/NEJM200008313430902 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1999

Schildhauer, TA; Bennett, AP; Wright, TM; Lane, JM; O'Leary, PF Intravertebral body reconstruction with an injectable in situ-setting carbonated apatite: biomechanical evaluation of a minimally invasive technique.
J ORTHOPAED RES. 1999; 17(1): 67-72. Doi: 10.1002/jor.1100170111
Web of Science PubMed FullText FullText_MUG

 

Weber, K; Hoffmann, A; Leb, G Therapy of osteoporosis: strategies for individualized treatment].
Wien Med Wochenschr. 1999; 149(16-17):489-492
PubMed

 

1998

Masaryk, P; Lunt, M; Benevolenskaya, L; Cannata, J; Dequeker, J; Dohenhof, C; Falch, JA; Felsenberg, D; Pols, HA; Poor, G; Reid, DM; Scheidt-Nave, C; Weber, K; O'Neill, T; Silman, AJ; Reeve, J Effects of menstrual history and use of medications on bone mineral density: the EVOS Study.
Calcif Tissue Int. 1998; 63(4):271-276 Doi: 10.1007%2Fs002239900525
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Erlacher, L; Kettenbach, J; Kiener, H; Graninger, W; Kainberger, F; Pietschmann, P Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
Wien Klin Wochenschr. 1997; 109(8): 270-274.
Web of Science PubMed Google Scholar

 

1985

Kopera, H The history of anabolic steroids and a review of clinical experience with anabolic steroids.
Acta Endocrinol Suppl (Copenh). 1985; 271(3):11-18 Doi: 10.1530/acta.0.109S00011
Web of Science PubMed FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum